Добавил:
kiopkiopkiop18@yandex.ru Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

3 курс / Патологическая физиология / Анафилактические_реакции_при_анестезии_и_интенсивной_терапии_Леви

.pdf
Скачиваний:
1
Добавлен:
24.03.2024
Размер:
9.76 Mб
Скачать

due to hydroxyethel starch infusion.— Europ. Surg. Res., 1976, 8.

317.Rinaldo J. E., Rogers R. Af. Adult respiratory distress syndrome.— N. Engl. J. Med., 1982, 306, 900—909.

318.Robinson J. A., Klodnycky Af. L., Loeb H. S., Racic Af. R., Gun- nar R. Af. Endotoxin, prekallikrein, complement and systemic vas­ cular resistance. Sequential measurements in man.— Amer. J. Med.,

1975, 59, 61—67.

319.Roitt /., Brostoff J. Immunology.— St. Louis: Mosby, 1985.

320.Rosenblatt H., Lawlor G. In: Manual of allergy and immunology.

Anaphylaxis/Eds. G. Lawlor, T. Fisher.— Boston: Little, Brown, 1981, 215—222.

321. Rosenthal Af. E., Dervinis A., Kassarich J. Bronchodilator activity of the prostaglandins, Ei and E2.— J. Pharmacol, exp. Ther., 1971, 178, 541—548.

322.Rosow С. E., Moss J., Philbin D. Af., Savarese J. J. Histamine re-, lease during morphine and fentanyl anesthesia.— Anesthesiology, 1982, 56, 93—96.

323.Rosow С. E., Philbin D. М., Keegan C. R., Moss J. Hemodynamics and histamine release during induction with sufentanil or fenta­ nyl.— Anesthesiology, 1984, 60, 489—491.

324.Royston D., Wilkes R. G. True anaphylaxis to suxamethonium chloride: a case report.— Brit. J. Anaesth., 1978, 50, 611—615.

325.Ruddy S., Gigli I., Austen K. F. The complement system of man.— N. Engl. J. Med., 1972, 287, 489—495, 592—596, 642—646.

326.Rush B., Lee N. L. Y. Clinical presentation of nonhaemolytic trans­ fusion reactions.— Anaesth. Intensive Care, 1980, 8, 125—131.

327.Safwat A., Dror A. Pulmonary capillary leak associated with methylmethacrylate during general anesthesia: a case report.—

Clin. Orthop., 1982, 168, 59—63.

*328. Sage D. Intradermal drug testing following anaphylactoid reactions during anaesthesia.— Anaesth. Intensive Care, 1981, 9, 381—386.

329.Samuel T. Antibodies reacting with salmon and human protamines in sera from infertile men and from vasectomized men and mon­ keys— Clin. Exp. Immunol., 1977, 30, 181—187.

330.Samuel T. Differentiation between antibodies to protamines and

somatic nuclear antigens by means of a comparative fluorescence

study on swollen nuclei of spermatozoa and somatic

cells.— Clin,

exp. Immunol., 1978, 32, 290—298.

sperm anti­

331. Samuel Т., Kolk A. H.

Rumke P. Autoimmunity to

gens in vasectomized men.— Clin. exp. Immunol., 1975, 21, 65— 74.

332.Samuel Т., Linnet L., Riimke P. Post-vasectomy autoimmunity to protamines in relaton to the formation of granulomas and sperm agglutinating antibodies.— Clin. exp. Immunol., 1978, 33, 261—269.

333.Samuelsson B., Hammarstrom S., Murphy R. C., Borgeat P. Leu-, kotrienes and slow reacting substance of anaphylaxis (SRS-A).— Allergy, 1980, 35, 375—381.

334.Sanchez Af. B., Paolillo М., Chacon R. S. et al. Protamine as a cau­ se of generalized allergic reactions to NPH insulin.— Lancet, 1982.

335.Sandoz Inc. Sandimmune. R Drug bulletin, 1984.

336.Schatz Af. Skin testing and incremental challenge in the evaluation of adverse 'reactions to local anesthetics.— J. Allergy clin. Immu­ nol., 1984, 74, 606—616.

337.Schatz Af., Wasserman S., Patterson R. The eosinophil and the lung.— Arch, intern. Med., 1978. 142, 1515—1519.

338.Schleimer R. P., MacGlashan D. W. Jr., Peters S . P. Inflammatory

171

 

mediators and mechanisms of release from purified human ba­

339.

sophils and mast

cells.— J. Allergy

clin. Immunol., 1984, 74,

473.

Schleitner

R. P M a c G la sh a n D. W. Jr., Schulman E. S.,

Pe­

 

ters S. P., Adams

G. K. I ll, Adkinson N. F. Jr., Lichtenstein L. M.

 

Human mast cells and basophils-structure, function, pharmacology,

340.

and biochemistry— Clin. Rev. Allergy, 1983, 1, 327—341.

Pe­

Schleimer

R. P.,

Schulman E. S.,

MacGlashan D. W. Jr.,

 

ters S. P.,

Hayes

E. C., Adams К. Ill, Lichtenstein L. М., Adkin­

 

son N. F, Effects of dexamethasone on mediator release from hu­

 

man lung fragments and purified human lung mast cells.— J. clin.

 

Invest., 1983, 71,

1830—1835.

 

 

341.Schmidt A. P., Taswell H. F., Gleich G. J. Anaphylactic transfusion reactions associated with anti-IgA antibody.— N. Engl. J. Med., 1969, 280, 188—193.

342.Schneiderman H., Hammerschmidt D. E., MacCall A. R., Jacob H. S.

Fatal complement-induced leukostasis after diatrizoate injection.—

J. A. M. A., 1983, 250, 2340—2342.

343.Schnitzler S., Renner H., Pfilller. Histamine release from rat mast

cells induced by

protamine sulfate and polyethylene amine.—

Agents Actions,

1981, 11, 73—74.

344.Schreiber A. D. Clinical immunology of the corticosteroids.— Prog, clin. Immunol., 1977, 3, 103—114.

345.Schreiber A. D. Immunohematology.— J. A. M. A., 1982, 248.

346.Schulman E. S., Newball H. H., Demers L. М., Fitzpatrick F. A., Adkinson N. F. Anaphylactic release of thromboxane A2, prosta-, glandin D2, and prostacyclin from human lung parenchyma.— Amer. Rev. resp. Dis., 1981, 124, 402—406.

347.Schwartz H.t Sher Т. H. Bisulfite sensitivity manifesting as aller­

gy to local dental anesthesia.— J. Allergy clin. Immunol., 1985, 75. 348. Schwartz L. B. Enzyme mediators of mast cells and basophils.—

Clin. Rev. Allergy, 1983,

1, 397—416.

349. Sczeklik J., Dubiel J. S.,

Mieczyslaw М., Puzik Z., Krol R H o r z e -

la T. Effects of prostaglandin Ej on pulmonary circulation in pa-,

tients with pulmonary

hypertension.— Brit. Heart. J., 1978, 40.

350.Sellow J. E., Mendelson L. М., Rosen J. P. Anaphylactic reaction in skin test-negative patients.— J. Allergy clin. Immunol., 1980, 65.

351.Shapira N., Schaff H. V., Piehler J. М., White R. D., Sill J. C.,

Pluth J. R. Cardiovascular effects of protamine sulfate in man —

J.thorac. cardiovasc. Surg., 1982, 84, 505—514.

352.Sheagren J. N. Septic shock and corticosteroids.— N. Engl. J. Med., 1981, 305, 456—458 (Editorial).

353.Sheffer A. L., Pennoyer D. S. Management of adverse drug reacti­ ons.— J. Allergy clin. Immunol., 1984, 74, 580—588.

354.Sheffer A. L. Unravelling the mystery of idiopathic anaphylaxis.—

N.Engl. J. Med., 1984, 311, 1248—1249.

355.Sheffer A. L. Anaphylaxis.— J. Allergy clin. Immunol., 1985, 75. 227—233.

356.Shehadi W. H. Adverse reactions to intravascularly administered contrast media.— Amer. J. Roentgenol., 1975, 124, 145— 152.

357.Shehadi W. H., Toniolo G. Adverse reactions to contrast media.— Radiology, 1980, 136, 299—302.

358.Siegel J., Rent R., Gewurz H. Interactions of C-reactive protein with the complement system: I. Protamine-induced cosumption of complement in acute phase sera.— J. exp. Med., 1974, 140, 637—647.

359.Silverman H. J., Van Hook C., Haponik E. F. Hemodynamic chan­ ges in human anaphylaxis.— Amer. J. Med., 1984, 77, 341—344.

172

360.Simon R. A. Adverse reactions to drug additives.— J. Allergy clin. Immunol., 1984, 74, 623—630.

361.Simon R. A., Green L.t Stevenson D. D. The incidence of sulfite sensitivity in an asthmatic population.— J. Allergy clin. Immunol., 1982, 69, 118.

362.Simon R. A., Shatz М., Stevenson D. D., Curry N-, Yamamoto F.,

Plow E., Ring J., Arroyave C. Radiographic contrast media infu-, sions. Measurements of histamine, complement, and fibrin split products and correlation with clinical parameters.— J. Allergy clin. Immunol., 1979, 63, 281—288.

363.Sinha A. K., Colman R. W. Prostaglandin Ej inhibits platelet ag­ gregation by a pathway independent of adenosine 3', 5'-monophos-; phate.— Science, 1978, 200, 202—203.

364.Smedegard G., Hedqvist, Dahlen S. E., Revenas B., Hammarstrom S., Samuelsson B. Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey.— Nature, 1982, 295, 327—329.

365.Smedegard G., Revenas В., Arfors K. Anaphylaxis in the monkey.— Acta Physiol. Scand., 1979, 106, 191—198.

366. Smedegard G., Revenas B., Lundberg C., Arfors K. Anaphylactic shock in monkeys passively sensitized with human reaginic se­ rum — Acta physiol, scand., 1981, 111, 239—247.

367.Smedegard G., Revenas B., Saldeen T. Aggregate anaphylaxis in the monkey: haematological and histological findings.— Int. Arch. Allergy, 1980, 61, 117—124.

368.Smith P. L. et al. Physiologic manifestations of human anaphyla­

xis.— J. clin. Invest., 1980, 66, 1072—1080.

369.Smith Laboratories. Chymiodiactin R post marketing surveillance report, 1984.

370.Sofer S., Bar-Ziv J., Scharf S. M. Pulmonary edema following re­ lief of upper airway obstruction — Chest, 1984, 86, 401—403.

371.Sogn D. D. Penicillin allergy.— J. Allergy clin. Immunol., 1984.

372.Spruill F. G., Minette L. J., Sturner W. Q. Two surgical deaths as­ sociated with cephalothin.— J. A. M. A., 1974, 229, 440—441.

373.Squire J. R. Tissue reactions to protein sensitization.—Brit. Med. J., 1952, 1, 1—7.

374. Stark B. J S u lliv a n T. J. Biphasic anaphylaxis.— J. Allergy clin. Immunol., 1985, 75, 210.

375.Steen P. A., Tinker J. H., Pluth J. R. Efficacy of dopamine, dobutamine, and epinephrine during emergence from cardiopulmonary

bypass.— Circulation, 1978, 57, 378—384.

376.Stenson W. F.t Parker C. W. Metabolites of arachidonic acid.— Clin. Rev. Allergy, 1983, 1, 369—384.

377.Sterback G. L. In: Emergency medicine: concepts and clinical practice.— St. Louis: Mosby, 1983, 1297.

378.Stewart W. J. et al. Increased risk of severe protamine reactions in

NPH insulindependent diabetics undergoing cardiac catheteriza­ tion.— Circulation, 1984, 70, 788—792.

379.Stoelting R. K. Allergic reactions during anesthesia.— Anesth. Analg., 1983, 62,341—356.

380.

Stoelting

R.

K.,Henry

D. P.,

Verburg К. М., McCammon

R. L.,

381.

King R.

D.,

Brown J.

W. Canad. Anaesth. Soc. J., 1984, 31,

534.

Stoelting

R.

K.,Miller

R. D.

In: Anaesthesia./Ed. R. D. Miller.—

New York: Churchill Livingstone, 1981, 539—560.

382.Sullivan T. J. Cardiac disorders in penicillin induced anaphylaxis: association with intravenous therapy.— J. A. M. A., 1982, 248.

173

383. Sullivan T. J. Allergic reactions to antimicrobial agents: A review of reactions to drugs not in the beta lactam anbiotic class.— J. Al­ lergy clin. Immunol., 1984, 74, 594—599.

384.Tannenbaum H., Ruddy S., Schur P. H. Acute anaphylaxis associa­ ted with serum complement depletion.— J. Allergy clin. Immunol., 1975, 56, 226—234.

385. Tanz R. D K e ttle k a m p N.,

Hirshman C. A. The effect of calcium

on cardiac anaphylaxis in guinea pig Lagendorff heart preparati­

ons.— Agents Actions, 1985,

16, 415—428.

386.Tauber A. /. Immunologic release of histamine and slow reacting substances of anaphylaxis from human lung vs effects of prosta­

glandins on release of histamine.— J. Immunol., 1973, 111, 27—32.

387.Teissner B., Brandslund I., Grunnet N., Hansen L. K., Thellesen Svehag S. E. Acute complement activation during an anaphylactoid

reaction

to blood transfusion and the disappearance rate of C3c

and C3d

from the circulation.— J. clin. Lab. Immunol., 1983, 12.

388.Terr A. /. Anaphylaxis.— Clin. Rev. Allergy, 1985, 3—23.

389.Tharp Af. D., Suvonrungsi R. Т., Sullivan Т. H. IgE-mediated rele­ ase of histamine from human cutaneous mast cells.— J. Immunol., 1982, 130, 1896—1901.

390.Thornton J. A., Lorenz W. Histamine and antihistamine in anaesthe­ sia and surgery.— Anaesthesia, 1983, 38, 373—379.

391.Thulstrip Af. The influence of leukocyte and thrombocyte incompa­ tibility of non-haemolytic transfusion reactions.— Vox Sang., 1971.

392.Tomasi Т. B. Human immunoglobulin A.—.N. Engl. J. Med., 1968,

279 1327_1330

393.Tomicheck R. C., Rosow C. G., Philben D. Af., Afoss /., Teplick R. S., Schneider R. C. Diazepam-fentanyl interaction — hemodynamic and

hormonal

effects in coronary artery surgery.— Anesth. Analg.,

1983,

62,

881—884.

394.Toniolo C. Secondary structure prediction of fish protamines.— Biochim. Biophys. Acta, 1980, 626, 420—427.

395.Travis D. W., Todres /. D., Shannon D. C. Pulmonary edema asso­ ciated with croup and epiglottitis.— Pediatrics, 1977, 59, 695—698.

396.Vallota E. H M iiller-Eberhard H. J. Formation of C3a and C5a anaphylatoxins in human serum after inhibition of the anaphyla-

toxin

inactivator.— J. exp. Med., 1973,

137, 1109—1123.

397. Verburg

Қ. Af., Bowsher R. R., Israel K. S., Black H. R., Hen­

ry D. P.

Histamine release by vancomycin in humans.— Fed. Proc.,

1985,

44,

1247.

 

398. Vercellotti G., Hammerschmidt D. E., Craddock P., Jacob H. S.

Activation of plasma complement by

perfluorocarbon artificial

blood.— Blood, 1982, 59, 1299—1304.

 

399. Vercellotti G. Af. Activation of plasma complement by perfluoro­ carbon artificial blood, mechanism prevention of adverse pulmona­

ry reaction — Clin. Res.,

1981, 29, 572A.

400. Vervloet D. Anaphylactic reactions to suxamethonium prevention

of mediatory release by

choline.— J. Allergy clin. Immunol., 1985,

76, 225—231.

 

401.

Vervloet D., Nizankowska, Arnaud A., Senft Af., Alazi Af., Char-

 

pin J. Adverse reactions to suxamethonium and other muscle rela-

402.

xants under general anesthesia.— J. Allergy

clin. Immunol., 1983.

Vigorito C„ Russo P., Picotti G. B.; Chiariello Af., Poto S., Maro-

 

ne G. Cardiovascular effects of histamine

infusions in man.—

 

J. cardiovasc. Pharmacol., 1983, 5, 531—537.

 

174

403.Vontz F. /С, Puestow Е. C.t Cahill D. J. Jr. Anaphylactic shock following protamine administration.— Amer. Surg., 1982, 48, 549.

404.Vyas G. N., Perkins H. A., Yang Y. M. Healthy blood donors with selective absence of immunoglobulin A. J. Lab. clin. Med., 1975.

405. Wakkers-Garritsen

B.

G H o u w e r z i j i J., Nater

J. P., Wak-

kers P. J. M. IgE

mediated adverse reactivity to a

radiocontrast

medium.--Ann. Allergy,

1976, 36, 122—126.

 

406.Ward H. N. Pulmonary infiltrates associated with leukoagglutinin transfusion reactions.— Ann. Intern. Med., 1970, 73, 669—694.

407.Ward H. N., Lipscomb Т., Cawley L. P. Pulmonary hypersensiti­

vity reaction after blood transfusion.— Arch, intern. Med., 1968.

408.Wasserman S. I. Mediators of immediate hypersensitivity.— J. Al­ lergy clin. Immunol., 1983, 72, 101—106.

409.Wasserman S. /. In: Allergy Principles and Practice. Anaphyla-. xis/Eds. E. Middleton, C. R. Reed, E. F. Ellis.— St. Louis: Mosby, 1983, 689—699.

410.Wasserman S. I., Goetzl E. J., Austen K. F. Preformed eosinophil

chemotactic factor of anaphylaxis (ECF-A).— J. Immunol., 1974, 112, 351—358.

411.Watkins /. Anaphylactoid reactions to I. V. substances.— Brit. J. Anaesth., 1979, 51, 51—60.

412.Watkins J. Etomidate. An immunologically safe anesthetic agent.— Anaesthesia, 1983, 38 (suppl.), 34—38.

413.Watkins J., Clarke R. S. J. Report of a symposium: Adverse res­

ponse to

intravenous

agents.— Brit. J. Anaesth., 1978,

50, 1159.

414. Watkins J., Clark A.,

Appleyard T. N., Padfield. Immune mediated

reactions

to althesin

 

(alphaxalone).— Brit. J. Anaesth.,

1976, 55.

415.Watkins J., Clarke R. S. J., Fee J. P. H. The relationship between reported atopy or allergy and immunoglobulins: a preliminary study.— Anaesthesia, 1981, 36, 582—585.

416.Watkins J., Salo M. et al. In: Trauma, Stress and Immunity in Anaesthesia and Surgery. Hypersensitivity response to drugs and plasma substitutes used in anesthesia and surgery/Eds J. Watkins,

M.Salo.— London: Butterworths and Co. Ltd., 1982, 254—291.

417.Watkins J., Thornton J. A. Immunological and nonimmunological mechanisms involved in adverse reactions to drugs.— Klin. Wschr., 1982, 60, 958—964.

418.Watson R. A., Ansbacher R B a r r y ЛІ, Deshon G. E., Ogee R. E.

Allergic reaction to protamine: a late complication of effective va­ sectomy? — Urology, 1983, 22, 493—495.

419.Webb-Johnson D. C., Andrews J. L Jr. Bronchodilator therapy.—

N.Engl. J. Med., 1977, 297, 476—482.

420.Webster В. H. Clinical presentation of haemolytic transfusion re­ actions.— Anaesth. intens. Care, 1980, 8, 115—119.

421.Weilber J. M. et al. Serious adverse reactions to protamine sulfate: are alternatives needed? — J. Allergy clin. Immunol., 1985.

422. Weiner

N. In:

The

pharmacologic basic of

therapcutics./Eds.

A. G.

Gilman,

L. S,

Goodman.— New York:

Macmillan, 1980,

138—175.

 

 

 

423.Weisman /. М., Rinaldo J. E., Rogers R. N. Positive ond-uxpinitory pressure in adult respiratory failure — N. Engl. J. Med., 1982, 30/.

424.Weiss J. W D r a z e n J. М., Coles N.t McFaddcn E. R.t Weller P. /■.. Corey E. Lewis R. A., Austen K. I\ Bronchoconstrietor effects of

leukotriene С in humans.— Science, 1982, 210, 190 198.

425.Weiss J. М., Drazen J. М., McFadden R. Jr., Weller P., Corey E. J., Lewis R. A.t Austen K. F. Airway constriction in normal humans

175